What is the Best Sperm Source and Way of Sperm Selection in Cases With Abnormal sORP Levels on the Day of ICSI?

NCT03360526 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 820

Last updated 2019-01-23

No results posted yet for this study

Summary

Does the level of statistic oxidation reduction potential (sORP) affects the choice of sperm source or sperm selection method used during ICSI.

Conditions

  • Oxidative Stress

Interventions

DEVICE

PICSI

Semen processing is done by double layer density gradient method followed by adding Sperm to the dot of hyaluronan on the PICSI dish, within minutes the bound sperm are attached by their acrosome to the surface of the dot. (Selecting an individual bound sperm with enhanced genetic and developmental integrity ensures that the sperm selected is the optimal sperm from the sample for oocyte injection.

PROCEDURE

TESA

Patients will undergo TESA which is performed by sticking a needle in the testis and aspirating fluid and tissue with negative pressure then examine the sample for presence of motile sperms followed by sample processing and oocyte injection.

Sponsors & Collaborators

  • The Cleveland Clinic

    collaborator OTHER
  • University of the Western Cape

    collaborator OTHER
  • Ganin Fertility Center

    lead OTHER

Principal Investigators

  • Eman Hasanen, BSc · Ganin Fertility Center, Cairo, Egypt

  • Hosam Zaki, MSc, FRCOG · Ganin Fertility Center, Cairo, Egypt

  • Khaled Elqusi, BSc · Ganin Fertility Center, Cairo, Egypt

  • Ashok Agarwal, Ph.D · American Center of reproductive medicine, Cleveland Clinic, Ohio, USA

  • Ralph Henkel, PhD · University of the Western Cape

  • Hanaa Elkhedr, ABB( ELD) · Ganin Fertility Center, Cairo, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-20
Primary Completion
2019-12-30
Completion
2019-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03360526 on ClinicalTrials.gov